(19)
(11) EP 1 220 716 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.08.2006 Bulletin 2006/33

(45) Mention of the grant of the patent:
29.03.2006 Bulletin 2006/13

(21) Application number: 00947347.1

(22) Date of filing: 14.07.2000
(51) International Patent Classification (IPC): 
B01L 11/00(2006.01)
G01N 1/34(2006.01)
B01L 3/00(2006.01)
(86) International application number:
PCT/US2000/019173
(87) International publication number:
WO 2001/005509 (25.01.2001 Gazette 2001/04)

(54)

A LOW BINDING LIQUID RETAINING AND FILTERING DEVICE

SCHWACH BINDENDE VORRICHTUNG ZUR RÜCKHALTUNG VON FLÜSSIGKEITEN UND ZUR FILTERUNG

DISPOSITIF DE FILTRATION ET DE RETENTION DE LIQUIDE A FAIBLE FIXATION


(84) Designated Contracting States:
CH DE FR GB IT LI

(30) Priority: 16.07.1999 US 145527 P

(43) Date of publication of application:
10.07.2002 Bulletin 2002/28

(60) Divisional application:
05075236.9 / 1559481

(73) Proprietor: Bristol-Myers Squibb Pharma Company
Princeton, NJ 08543-4000 (US)

(72) Inventor:
  • TORTORELLA, Micky, Daniel
    Newark, DE 19702 (US)

(74) Representative: Gambell, Derek et al
Graham Watt & Co LLP St Botolph's House 7-9 St Botolph's Road
Sevenoaks Kent TN13 3AJ
Sevenoaks Kent TN13 3AJ (GB)


(56) References cited: : 
EP-A- 0 106 764
US-A- 3 870 639
US-A- 4 210 697
US-A- 4 427 415
US-A- 4 623 461
US-A- 4 683 058
US-A- 4 891 134
US-A- 4 990 253
US-A- 5 853 894
US-A- 5 888 831
US-A- 6 103 195
US-A- 3 661 265
US-A- 4 136 036
US-A- 4 214 993
US-A- 4 436 631
US-A- 4 666 991
US-A- 4 777 021
US-A- 4 902 481
US-A- 5 104 533
US-A- 5 882 943
US-A- 5 935 858
   
  • Baxter Scientific Products, "Centri/Por TM", Diposable Centrifuge Concentrators, page "RD 26", 1991, XP002931418.
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).